SCHEMBL21005226

SCHEMBL21005226

CSc1ccc(Oc2cncc(F)c2)c2c1C(O)C(F)(F)C2

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ VEGFA P15692 13/20 0.64
▸ EPAS1 Q99814 14/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21005013 0.89 VEGFA (0.68) VEGFAEPAS1
SCHEMBL21005092 0.88 EPAS1 (0.70) VEGFAEPAS1
SCHEMBL21005057 0.88 EPAS1 (0.70) VEGFAEPAS1
SCHEMBL21004991 0.88 VEGFA (0.67) VEGFAEPAS1
SCHEMBL21005015 0.85 EPAS1 (0.72) VEGFAEPAS1
SCHEMBL21005008 0.83 VEGFA (0.70) VEGFAEPAS1
SCHEMBL21005009 0.83 VEGFA (0.70) VEGFAEPAS1
SCHEMBL18688486 0.80 VEGFA (0.72) VEGFAEPAS1
SCHEMBL21005439 0.79 EPAS1 (0.69) VEGFAEPAS1
SCHEMBL16560893 0.79 VEGFA (1.00) VEGFAEPAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3417851-B1 ARYL ETHERS AND USES THEREOF PELOTON THERAPEUTICS INC (US) 2020-07-22 — — EP disclosed
EP-3417852-B1 ARYL ETHERS AND USES THEREOF PELOTON THERAPEUTICS INC (US) 2020-02-19 — — EP disclosed
EP-3043784-B9 ARYL ETHERS AND USES THEREOF PELOTON THERAPEUTICS INC (US) 2019-11-20 — — EP disclosed
EP-3043784-B1 ARYL ETHERS AND USES THEREOF PELOTON THERAPEUTICS INC (US) 2019-05-15 — — EP disclosed
Send feedback